Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High-risk Non-Muscle Invasive Bladder Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT04730232
What this trial is testing

Tilelizumab Combined With Nab-Paclitaxel for High-Risk Non-Muscle-Invasive Urothelial Bladder Carcinoma Which is Not Completely Resectable

Who this might be right for
High-RiskNon-Muscle Invasive Bladder Urothelial Carcinoma
Tianjin Medical University Second Hospital 63
Large-scale testing (Phase 3)Active Not RecruitingNCT06462001
What this trial is testing

BCG + MMC: Adding Mitomycin C to BCG in High-risk, Non-muscle-invasive Bladder Cancer

Who this might be right for
Transitional Cell CarcinomaTransurethral Resection
Nottingham University Hospitals NHS Trust 500
Large-scale testing (Phase 3)Looking for participantsNCT07480356
What this trial is testing

Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer

Who this might be right for
Bladder (Urothelial, Transitional Cell) CancerNon-Muscle Invasive Bladder CarcinomaNon-muscle Invasive Bladder Cancer With Carcinoma in Situ
Protara Therapeutics 284
Post-approval studies (Phase 4)Study completedNCT02214602
What this trial is testing

Value of Immediate Post-operative Intravesical Epirubicin in Intermediate&High Risk Non Muscle Invasive Bladder Cancer

Who this might be right for
Carcinoma of Urinary Bladder, Superficial
Mansoura University 240
Post-approval studies (Phase 4)UnknownNCT03790384
What this trial is testing

Sequential Combination Therapy in Bladder Cancer

Who this might be right for
Bladder Cancer
Azienda Ospedaliera "Sant'Andrea" 140
Not applicableStudy completedNCT07798479
What this trial is testing

Age and Bladder Cancer Outcomes After BCG Treatment: A Multicenter Study

Who this might be right for
Bladder CancerNMIBC
Insel Gruppe AG, University Hospital Bern 64
Not applicableStudy completedNCT07642102
What this trial is testing

Evaluation of the Role of Early Second Look TURBT in Management of High Risk Non Muscle Invasive Bladder Cancer

Who this might be right for
Bladder (Urothelial, Transitional Cell) Cancer Superficial (Non-Invasive)Transurethral Resection of Bladder Tumor
Ain Shams University 70
Testing effectiveness (Phase 2)WithdrawnNCT02143804
What this trial is testing

Safety and Efficacy of CG0070 Oncolytic Virus Regimen in Patients With High Grade Non-Muscle Invasive Bladder Cancer

Who this might be right for
Bladder CancerHigh GradeNon Muscle Invasive
CG Oncology, Inc.
Testing effectiveness (Phase 2)Study completedNCT03636256
What this trial is testing

Evaluation of NanoDoce® in Participants With Urothelial Carcinoma

Who this might be right for
Bladder CancerUrothelial CarcinomaUrinary Bladder Neoplasm+6 more
NanOlogy, LLC 36
Testing effectiveness (Phase 2)Active Not RecruitingNCT04706598
What this trial is testing

Safety and Efficacy of Camrelizumab for High-risk NMIBC Failing BCG Treatment

Who this might be right for
Urinary Bladder NeoplasmsImmunotherapy
Fudan University 25
Not applicableNot Yet RecruitingNCT07231809
What this trial is testing

Hyperthermic Intravesical Chemotherapy (HIVEC) in BCG-Non-Responsive High-Grade NMIBC Patients

Who this might be right for
Non Muscle Invasive Bladder CancerBladder CancerCarcinoma in Situ of Bladder+2 more
AC.TA. S.r.l. 50
Large-scale testing (Phase 3)UnknownNCT06241755
What this trial is testing

Clinical Trial for Evaluating the Efficacy and Safety of BCG for Therapeutic Use in the Prevention of Postoperative Recurrence of Medium/High-risk Non-muscle Invasive Bladder Cancer (NMIBC)

Who this might be right for
Non-Muscle Invasive Bladder Cancer
Chengdu CoenBiotech Co., Ltd 412
Testing effectiveness (Phase 2)Study completedNCT04311580
What this trial is testing

Intravesical Electromotive Mitomycin After Bacillus Calmette-Guérin Failure

Who this might be right for
Bladder Cancer
University of Rome Tor Vergata 52
Testing effectiveness (Phase 2)UnknownNCT03759496
What this trial is testing

Efficacy of Durvalumab in Non-muscle-invasive Bladder Cancer

Who this might be right for
Bladder Cancer
Hellenic GenitoUrinary Cancer Group 39
Testing effectiveness (Phase 2)Study completedNCT04593862
What this trial is testing

Bladder Cancer and ExeRcise Training During IntraVesical ThErapy

Who this might be right for
Bladder Cancer
University of Alberta 25
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07064863
What this trial is testing

A Tumor Immune Biomarker Guided Approach for Improving Response to BCG in Patients With High-risk NMIBC.

Who this might be right for
NMIBCNon-Muscle Invasive Bladder Urothelial CarcinomaBladder (Urothelial, Transitional Cell) Cancer+1 more
Queen's University 31
Testing effectiveness (Phase 2)Study completedNCT01939756
What this trial is testing

Intravesical Natural Baobab Oil in the Management of BCG-induced Lower Urinary Tract Symptoms

Who this might be right for
Superficial Bladder CancerLower Urinary Tract Symptoms
Savino M. Di Stasi 50
Early research (Phase 1)WithdrawnNCT04089163
What this trial is testing

Toca 511 & Toca FC in Patients With Recurrent High Grade Non-Muscle Invasive Bladder Cancer (Toca 8)

Who this might be right for
Bladder Cancer
Tocagen Inc.
Not applicableUnknownNCT05332353
What this trial is testing

Machine Learning-Based Prediction of BCG Response in High-Risk Non-Muscle Invasive Bladder Cancer Patients

Who this might be right for
Non-Muscle Invasive Bladder Cancer
Mansoura University 100
Early research (Phase 1)Study completedNCT05085977
What this trial is testing

Safety and Toxicity Study of Intravesical Instillation of TARA-002 in Adults with High-grade Non-muscle Invasive Bladder Cancer (Phase 1a)

Who this might be right for
Non-muscle Invasive Bladder Cancer
Protara Therapeutics 12
Next Page